Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423
Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns TS, Abramowitz MK, Levy R, Kumar N, Mokrzycki MH (2020) AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol 31(9):2145–2157
Article CAS PubMed PubMed Central Google Scholar
Rewa O, Bagshaw SM (2014) Acute kidney injury—epidemiology, outcomes and economics. Nat Rev Nephrol 10(4):193–207
Article CAS PubMed Google Scholar
Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu C-y (2013) Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol 24(1):37–42
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423
Odutayo A, Wong CX, Farkouh M, Altman DG, Hopewell S, Emdin CA, Hunn BH (2017) AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol 28(1):377–387
Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J (2021) Acute kidney injury. Nat Rev Dis Primers 7(1):52
Legrand M, Rossignol P (2020) Cardiovascular consequences of acute kidney injury. N Engl J Med 382(23):2238–2247
Article CAS PubMed Google Scholar
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179–c184
Liao JK (2005) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96(5):24–33
Mihos CG, Pineda AM, Santana O (2014) Cardiovascular effects of statins, beyond lipid-lowering properties. Pharmacol Res 88:12–19
Article CAS PubMed Google Scholar
Oesterle A, Laufs U, Liao JK (2017) Pleiotropic effects of statins on the cardiovascular system. Circ Res 120(1):229–243
Article CAS PubMed PubMed Central Google Scholar
Morofuji Y, Nakagawa S, Ujifuku K, Fujimoto T, Otsuka K, Niwa M, Tsutsumi K (2022) Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer. Pharmaceuticals 15(2):151
Article CAS PubMed PubMed Central Google Scholar
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G (2019) Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 39(2):e38–e81
Article CAS PubMed Google Scholar
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. J Am Coll Cardiol 74(10):e177–e232. https://doi.org/10.1016/j.jacc.2019.03.010
Article PubMed PubMed Central Google Scholar
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA (2019) 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis 290:140–205
Brar S, Ye F, James M, Hemmelgarn B, Klarenbach S, Pannu N, Collaboration ICD (2016) Statin use and survival after acute kidney injury. Kidney Int Rep 1(4):279–287
Article PubMed PubMed Central Google Scholar
Wu C-L, Kor C-T, Chang C-C, Chiu P-F, Tarng D-C, Hsu C-C (2008) Association of statin use with mortality after dialysis-requiring acute kidney injury: a population-based cohort study. Mayo Clinic Proceedings, vol 10. Elsevier, New York, pp 1474–1483
Johnson ABL, Pollard T, Horng S, Celi LA, Mark R (2022) MIMIC-IV (version 2.0). PhysioNet. https://doi.org/10.13026/rrgf-xw32
Kdigo A, Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2(1):1–138
Vincent J-L, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart C, Suter P, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Springer-Verlag, New York
Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS (2016) Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA 316(12):1289–1297
Article CAS PubMed Google Scholar
Almeida SO, Budoff M (2019) Effect of statins on atherosclerotic plaque. Trends Cardiovasc Med 29(8):451–455
Article CAS PubMed Google Scholar
Yasuda H, Yuen PS, Hu X, Zhou H, Star RA (2006) Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69(9):1535–1542
Article CAS PubMed PubMed Central Google Scholar
Chinaeke EE, Love BL, Magagnoli J, Yunusa I, Reeder G (2021) The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis. Pharmacotherapy. 41(2):162–171
Article CAS PubMed PubMed Central Google Scholar
Makris K, Spanou L (2016) Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochemist Rev 37(2):85
Vahedian-Azimi A, Heidari Beni F, Fras Z, Banach M, Mohammadi SM, Jamialahmadi T, Sahebkar A (2023) Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis. Arch Med Sci 19(4). https://doi.org/10.5114/aoms/159992
Gameiro J, Marques F, Lopes JA (2021) Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J 14(3):789–804
Article CAS PubMed Google Scholar
See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, Toussaint ND, Bellomo R (2019) Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int 95(1):160–172
Wanner C, Tonelli M (2014) KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303–1309
Article CAS PubMed Google Scholar
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, Gillman MW, Kemper AR, Krist AH, Kurth AE (2016) Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA 316(19):1997–2007
Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M (2022) Statin Use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force. JAMA 328(8):754–771
Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, Michos ED, Itchhaporia D, Nasir K, Alam M (2020) Statin prescription rates, adherence, and associated clinical outcomes among women with PAD and ICVD. Cardiovasc Drugs Ther 34:745–754
Article CAS PubMed Google Scholar
Clough JD, Martin SS, Navar AM, Lin L, Hardy NC, Rogers U, Curtis LH (2019) Association of primary care providers’ beliefs of statins for primary prevention and statin prescription. J Am Heart Assoc 8(3):e010241
Article PubMed PubMed Central Google Scholar
Sawano M, Kohsaka S, Abe T, Inohara T, Maekawa Y, Ueda I, Sueyoshi K, Suzuki M, Noma S, Numasawa Y (2017) Patterns of statin non-prescription in patients with established coronary artery disease: a report from a contemporary multicenter Japanese PCI registry. PLoS One 12(8):e0182687
Article PubMed PubMed Central Google Scholar
Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M (2022) The many roles of cholesterol in sepsis: a review. Am J Respir Crit Care Med 205(4):388–396
Comments (0)